Historical record - last NADAC effective date: 5/20/2015

Product Information

LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0487 per EA under NDC 65862004501. Its NADAC has been published 78 times since Nov 28, 2013.

FDA first approved this application on Mar 14, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Lisinopril and Hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB

Lisinopril and Hydrochlorothiazide
$0.0487per EA
High Outlier

Strength

25; 20 mg/1; mg/1

NDC

65862004501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

5/20/2015

Approval Type

Generic (ANDA)

FDA Application

ANDA077606

FDA Approved

3/14/2006

TE Code

AB

On Market Since

3/14/2006

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB has been published 78 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0487 per EA
All-time high$0.0548 (Apr 16, 2014)
All-time low$0.0450 (Mar 18, 2015)
Median price$0.0489
Average price$0.0495
Largest weekly change+6.1% (May 20, 2015)
Weeks tracked78
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-1.3%

Last surveyed May 20, 2015 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.0487 per EA (NDC 65862004501), effective May 20, 2015.

How has the price of LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB changed over time?

Over the history we have for it, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB has held within roughly two percent of its current level. It has been tracked across 78 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB?

Since Nov 28, 2013, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB has ranged from a low of $0.0450 (Mar 18, 2015) to a high of $0.0548 (Apr 16, 2014), with a median of $0.0489 per EA.

Are there cheaper alternatives to LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB, is $0.0405 per EA — about 17% below LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB.

Who manufactures LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB?

LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB (NDC 65862004501) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.